| 2025-06-16 19:41 | CC:SVA | Sernova Biotherapeutics Inc | 0.16 | Street Wire165 | Sernova ex Haghighat pleads not guilty |
| 2025-06-13 16:30 | CC:SVA | Sernova Biotherapeutics Inc | 0.165 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-06-13 16:30 | CC:SVA | Sernova Biotherapeutics Inc | 0.165 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-06-02 20:26 | CC:SVA | Sernova Biotherapeutics Inc | 0.17 | News Release200 | Sernova appoints Rigby as interim chair |
| 2025-05-26 02:26 | CC:SVA | Sernova Biotherapeutics Inc | 0.195 | News Release200 | Sernova chair Haghighat resigns |
| 2025-05-23 19:00 | CC:SVA | Sernova Biotherapeutics Inc | 0.195 | Street Wire165 | Sernova's Haghighat charged for insider trading |
| 2025-05-22 14:58 | CC:SVA | Sernova Biotherapeutics Inc | 0.22 | News Release200 | Sernova Biotherapeutics forms clinical advisory board |
| 2025-05-14 15:52 | CC:SVA | Sernova Biotherapeutics Inc | 0.21 | News Release200 | Sernova talks interim data from Cell Pouch trial |
| 2025-04-17 17:09 | CC:SVA | Sernova Biotherapeutics Inc | 0.20 | News Release200 | Sernova closes $4-million term loan from Navigate |
| 2025-04-15 18:48 | CC:SVA | Sernova Biotherapeutics Inc | 0.18 | News Release200 | Sernova to highlight Cell Pouch organ at Rome meeting |
| 2025-04-01 17:17 | CC:SVA | Sernova Biotherapeutics Inc | 0.165 | News Release200 | Sernova to continue to Cohort C T1D trial in H2 2025 |
| 2025-03-14 16:03 | CC:SVA | Sernova Biotherapeutics Inc | 0.175 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-03-14 15:58 | CC:SVA | Sernova Biotherapeutics Inc | 0.175 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-03-10 17:13 | CC:SVA | Sernova Biotherapeutics Inc | 0.185 | News Release200 | Sernova appoints Calias as CDO, R&D head |
| 2025-03-05 12:32 | CC:SVA | Sernova Biotherapeutics Inc | 0.19 | News Release200 | Sernova arranges $1-million debenture financing |
| 2025-03-03 19:48 | CC:SVA | Sernova Biotherapeutics Inc | 0.20 | News Release200 | Sernova receives FDA clearance for IND application |
| 2025-02-07 18:04 | CC:SVA | Sernova Corp | 0.21 | Change Name280 | Sernova name change to Sernova Biotherapeutics |
| 2025-02-03 18:58 | CC:SVA | Sernova Corp | 0.205 | News Release200 | Sernova applies for investigational new drug to FDA |
| 2025-01-30 16:44 | CC:SVA | Sernova Corp | 0.21 | News Release200 | Sernova appoints Haghighat as chair |
| 2025-01-13 11:37 | CC:SVA | Sernova Corp | 0.225 | News Release200 | Sernova shareholders elect six directors at ASM |
| 2024-12-23 17:34 | CC:SVA | Sernova Corp | 0.22 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
| 2024-12-23 17:27 | CC:SVA | Sernova Corp | 0.22 | SEDAR MD & A815 | SEDAR MD & A |
| 2024-12-23 17:21 | CC:SVA | Sernova Corp | 0.22 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-12-20 16:42 | CC:SVA | Sernova Corp | 0.23 | News Release200 | Sernova reschedules AGSM to Jan. 10 |
| 2024-12-02 18:35 | CC:SVA | Sernova Corp | 0.22 | News Release200 | Sernova enters product development LOI in Saudi Arabia |
| 2024-10-11 09:27 | CC:SVA | Sernova Corp | 0.26 | News Release200 | Sernova appoints Parsons as CFO |
| 2024-09-19 09:49 | CC:SVA | Sernova Corp | 0.245 | News Release200 | Sernova appoints Paterson to board |
| 2024-09-16 16:46 | CC:SVA | Sernova Corp | 0.245 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-09-16 16:46 | CC:SVA | Sernova Corp | 0.245 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-09-13 08:06 | CC:SVA | Sernova Corp | 0.255 | In the News525 | Globe says Leede's Loe rates Sernova "speculative buy" |
| 2024-09-12 15:38 | CC:SVA | Sernova Corp | 0.295 | News Release200 | Sernova talks data from Cell Pouch phase I/II trial |
| 2024-09-04 10:24 | CC:SVA | Sernova Corp | 0.275 | News Release200 | Sernova closes $5.2-million private placement |
| 2024-08-29 13:54 | CC:SVA | Sernova Corp | 0.26 | News Release200 | Sernova's financing overubscribed at $4.7-million |
| 2024-08-20 10:05 | CC:SVA | Sernova Corp | 0.215 | News Release200 | Sernova arranges $4-million private placement |
| 2024-08-15 07:00 | CC:SVA | SERNOVA CORP. J | 0.23 | News Release200 | Lead Investigator for Sernova's Clinical Trial with Cell Pouch for Type 1 Diabetes to Deliver Oral Presentation at the 2024 EASD Annual Meeting |
| 2024-08-12 15:24 | CC:SVA | Sernova Corp | 0.245 | News Release200 | Sernova appoints Rigby as CEO |
| 2024-07-15 10:16 | CC:SVA | Sernova Corp | 0.305 | News Release200 | Sernova names Rigby executive chairman |
| 2024-06-25 10:53 | CC:SVA | Sernova Corp | 0.37 | News Release200 | Sernova completes phase I/II trial patient enrolment |